Caxton

Caxton Corp as of March 31, 2025

Portfolio Holdings for Caxton Corp

Caxton Corp holds 12 positions in its portfolio as reported in the March 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Rezolute Com New (RZLT) 75.3 $3.8M 1.3M 2.90
Spdr Gold Tr Gold Shs (GLD) 7.4 $374k 1.3k 288.21
Berkshire Hathaway Inc Del Cl B New (BRK.B) 4.9 $249k 467.00 532.80
Mind Medicine Mindmed Com New (MNMD) 3.9 $199k 34k 5.85
Bicara Therapeutics (BCAX) 2.8 $143k 11k 13.03
Compass Therapeutics (CMPX) 1.6 $83k 44k 1.90
Lexeo Therapeutics (LXEO) 1.2 $62k 18k 3.47
Kyverna Therapeutics (KYTX) 0.9 $44k 23k 1.93
Cardiff Oncology (CRDF) 0.8 $42k 13k 3.14
Inhibikase Therapeutics Com New (IKT) 0.7 $36k 16k 2.19
Adicet Bio (ACET) 0.3 $13k 18k 0.76
Context Therapeutics (CNTX) 0.2 $11k 18k 0.61